Neonatal BCG Vaccination Reduces Interferon-γ Responsiveness to Heterologous Pathogens in Infants From a Randomized Controlled Trial. [electronic resource]
Producer: 20210219Description: 1999-2009 p. digitalISSN:- 1537-6613
- Age Factors
- Australia
- BCG Vaccine -- administration & dosage
- Bacterial Infections -- immunology
- Female
- Follow-Up Studies
- Host Microbial Interactions -- immunology
- Humans
- Immunity, Heterologous
- Immunization Schedule
- Immunogenicity, Vaccine
- Infant
- Infant, Newborn
- Interferon-gamma -- blood
- Male
- Mass Vaccination -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.